Zamboni; Robert
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zamboni; Robert.The latest application filed is for "crystals".
Company Profile
9.21.24
- Zamboni; Robert - Beaconsfield CA
- Zamboni; Robert - San Francisco CA
- ZAMBONI; Robert - Palo Alto CA
- Zamboni; Robert - Toronto CA
- Zamboni; Robert - Pointe Claire CA
- Zamboni; Robert - Quebec CA
- Zamboni; Robert - Rahway NJ
- Zamboni; Robert - Point-Claire CA
- Zamboni; Robert - Point-Clair CA
- Zamboni; Robert - Longueuil CA
Patent Activity
| Patent | Date |
|---|---|
| Triazole glycolate oxidase inhibitors Grant 11,401,246 - Maag , et al. August 2, 2 | 2022-08-02 |
| Crystals App 20220204536 - MCGUIRK; Paul Robert ; et al. | 2022-06-30 |
| Novel Prodrug Salts App 20220143048 - Pelletier; Marc F. ; et al. | 2022-05-12 |
| Processes For Preparing Ag-10, Its Intermediates, And Salts Thereof App 20220041558 - Chand; Pooran ; et al. | 2022-02-10 |
| Triazole Glycolate Oxidase Inhibitors App 20210403439 - MAAG; Hans ; et al. | 2021-12-30 |
| Crystals Grant 11,117,909 - Mcguirk , et al. September 14, 2 | 2021-09-14 |
| Processes for preparing AG-10, its intermediates, and salts thereof Grant 11,078,162 - Chand , et al. August 3, 2 | 2021-08-03 |
| Prodrug salts Grant 11,071,744 - Pelletier , et al. July 27, 2 | 2021-07-27 |
| Benzoxazinone Compounds As Klk5/7 Dual Inhibitors App 20210101911 - BETZ; Andreas ; et al. | 2021-04-08 |
| Small Molecule Modulators Of Pantothenate Kinases App 20210061788 - LEE; Richard E. ; et al. | 2021-03-04 |
| Methods Of Treating Disorders Associated With Castor App 20210023081 - JACKOWSKI; Suzanne ; et al. | 2021-01-28 |
| RAF-degrading conjugate compounds Grant 10,787,443 - Zamboni , et al. September 29, 2 | 2020-09-29 |
| Novel Prodrug Salts App 20200297740 - PELLETIER; Marc F. ; et al. | 2020-09-24 |
| Processes For Preparing Ag-10, Its Intermediates, And Salts Thereof App 20200247756 - Kind Code | 2020-08-06 |
| Process for preparing AG-10, its intermediates, and salts thereof Grant 10,513,497 - Chand , et al. Dec | 2019-12-24 |
| Crystals App 20190185496 - MCGUIRK; Paul Robert ; et al. | 2019-06-20 |
| Prodrug salts Grant 10,258,636 - Pelletier , et al. | 2019-04-16 |
| Cephem Compounds with Latent Reactive Groups App 20190100534 - SUTTON; Larry D. ; et al. | 2019-04-04 |
| Raf-degrading Conjugate Compounds App 20180346457 - ZAMBONI; Robert ; et al. | 2018-12-06 |
| Processes For Preparing AG-10, Its Intermediates, and Salts Thereof App 20180237396 - Chand; Pooran ; et al. | 2018-08-23 |
| Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- dro-1,8-naphthyridin-3-yl)acrylamide Grant 10,035,813 - Partridge , et al. July 31, 2 | 2018-07-31 |
| Novel Prodrug Salts App 20180169118 - PELLETIER; Marc F. ; et al. | 2018-06-21 |
| Prodrug salts Grant 9,827,253 - Pelletier , et al. November 28, 2 | 2017-11-28 |
| Novel Prodrug Salts App 20160264604 - PELLETIER; Marc F. ; et al. | 2016-09-15 |
| Prodrug Derivatives Of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- Dro-1,8-naphthyridin-3-yl)acrylamide App 20150065415 - Partridge; John J. ; et al. | 2015-03-05 |
| Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin- -3-yl)acrylamide Grant 8,901,105 - Partridge , et al. December 2, 2 | 2014-12-02 |
| Prodrug Derivatives Of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- Dro-1,8-naphthyridin-3-yl)acrylamide App 20140051666 - Partridge; John J. ; et al. | 2014-02-20 |
| Pyridopyridazine compounds, compositions and methods of use Grant 8,222,251 - Kaizerman , et al. July 17, 2 | 2012-07-17 |
| Pyridopyridazine compounds, compositions and methods of use App 20090099173 - Kaizerman; Jacob ; et al. | 2009-04-16 |
| Ptb1b photoprobes App 20070161542 - Ramachandran; Chidambaram ; et al. | 2007-07-12 |
| Substituted tetrahydrocarbazole and cyclopentanoindole derivatives Grant 7,019,022 - Beaulieu , et al. March 28, 2 | 2006-03-28 |
| Nitric oxide releasing selective cyclooxygenase-2 inhibitors App 20060058363 - Wang; Zhaoyin ; et al. | 2006-03-16 |
| Substituted tetrahydrocarbazole and cyclopentanoindole derivatives App 20050154044 - Beaulieu, Christian ; et al. | 2005-07-14 |
| Pyrazinones, compositions containing such compounds and methods of use Grant 6,699,856 - Han , et al. March 2, 2 | 2004-03-02 |
| Pyrazinones, compositions containing such compounds and methods of use App 20030236402 - Han, Yongxin ; et al. | 2003-12-25 |
| Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore Grant 6,627,656 - Gallant , et al. September 30, 2 | 2003-09-30 |
| Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 App 20030045478 - Han, Yongxin ; et al. | 2003-03-06 |
| Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore App 20020082266 - Gallant, Michel ; et al. | 2002-06-27 |
| Quinoline ether alkanoic acids Grant 5,232,916 - Zamboni , et al. August 3, 1 | 1993-08-03 |
| Quinoline ether alkanoic acids Grant 5,102,881 - Zamboni , et al. April 7, 1 | 1992-04-07 |
| Pyridyl styrene dialkanoic acids as anti-leukotriene agents Grant 5,004,743 - Young , et al. April 2, 1 | 1991-04-02 |
| 2-substituted quinolines useful as leukotriene antagonists Grant 4,962,203 - Young , et al. October 9, 1 | 1990-10-09 |
| Benzoheterazoles Grant 4,957,932 - Young , et al. September 18, 1 | 1990-09-18 |
| 2-substituted quinoline dioic acids and pharmaceutical compositions Grant 4,851,409 - Young , et al. July 25, 1 | 1989-07-25 |
| 2-[(substituted)-phenoxymethyl]quinolines Grant 4,661,499 - Young , et al. April 28, 1 | 1987-04-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 